Here's Why Investors Should Consider Retaining Xylem Stock Now

13.05.25 15:54 Uhr

Werte in diesem Artikel
Aktien

12,80 EUR -0,20 EUR -1,54%

110,95 EUR -1,40 EUR -1,25%

Indizes

5.802,8 PKT -39,2 PKT -0,67%

Xylem Inc. XYL is witnessing strength in the Measurement & Control Solutions segment, driven by robust demand for advanced technology solutions like smart metering and other applications. Growth in the transport application business, driven by the increased infrastructure projects in the United States, is boosting the Water Infrastructure segment’s performance. Recovery in the Applied Water segment, supported by higher demand for building solutions applications, also holds promise for the segment.Exiting first-quarter 2025, the company’s backlog totaled $5.1 billion, backed by strength across all regions. Strength in utilities, industrial and building solutions end markets is a key catalyst to the company’s growth.  For 2025, Xylem expects revenues to be $8.7-$8.8 billion, indicating growth of 1-2% on a year-over-year basis.The company remains focused on acquiring businesses to gain access to new customers, regions and product lines. For instance, in December 2024, XYL completed the acquisition of a majority stake in Idrica. The inclusion of Idrica’s technology will offer growth opportunities for Xylem and enable it to penetrate new markets and deliver intelligent solutions to its customers. Also, in May 2023, XYL acquired Evoqua, a mission-critical water treatment solutions and services provider. Evoqua’s advanced water and wastewater treatment capabilities and exposure to key industrial markets complement Xylem’s portfolio of solutions across the water cycle. Acquisitions contributed $786 million to XYL’s total revenues in 2024.XYL remains committed to rewarding its shareholders through dividend payouts and share buybacks. In the first quarter of 2025, Xylem paid dividends of $98 million, reflecting an increase of 11.4% year over year. It repurchased shares worth $12.9 million in the same quarter. Also, in February 2025, the company hiked its dividend rate by 11%.Image Source: Zacks Investment ResearchIn the past six months, the Zacks Rank #3 (Hold) company has gained 4.7% compared with the industry’s 2.8% growth.Despite the positives, high debt levels are also likely to hurt Xylem’s profitability. It exited the first quarter with long-term debt of $1.97 billion. Also, considering its high debt level, its cash and cash equivalents of $1.06 billion do not look impressive.XYL has been grappling with rising operating costs and expenses. After witnessing a surge of 15.1% year over year in 2024, the company’s cost of revenues increased 1.6% in first-quarter 2025. Also, in 2024, its selling, general and administrative expenses surged 8.8% due to additional operational expenditure from the acquisition of Evoqua.Key PicksSome better-ranked stocks from the same space are discussed below.Federal Signal Corporation FSS currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.FSS delivered a trailing four-quarter average earnings surprise of 6.4%. In the past 60 days, the Zacks Consensus Estimate for Federal Signal’s 2025 earnings has increased 1.3%.Unifirst Corporation UNF currently carries a Zacks Rank of 2. UNF delivered a trailing four-quarter average earnings surprise of 12.3%. In the past 60 days, the consensus estimate for Unifirst’s fiscal 2025 (ending August 2025) earnings has increased 4.1%.AptarGroup, Inc. ATR presently carries a Zacks Rank of 2. ATR delivered a trailing four-quarter average earnings surprise of 7.3%. In the past 60 days, the consensus estimate for AptarGroup’s 2025 earnings has increased 4.3%.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Unifirst Corporation (UNF): Free Stock Analysis Report AptarGroup, Inc. (ATR): Free Stock Analysis Report Federal Signal Corporation (FSS): Free Stock Analysis Report Xylem Inc. (XYL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: NOW und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf NOW

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf NOW

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Xylem Inc.

Wer­bung

Analysen zu Xylem Inc.

DatumRatingAnalyst
14.05.2019Xylem Market PerformCowen and Company, LLC
19.12.2018Xylem BuyStifel, Nicolaus & Co., Inc.
04.08.2017Xylem OutperformBMO Capital Markets
02.08.2017Xylem OutperformRBC Capital Markets
23.06.2017Xylem OutperformBMO Capital Markets
DatumRatingAnalyst
19.12.2018Xylem BuyStifel, Nicolaus & Co., Inc.
04.08.2017Xylem OutperformBMO Capital Markets
02.08.2017Xylem OutperformRBC Capital Markets
23.06.2017Xylem OutperformBMO Capital Markets
15.05.2017Xylem OverweightBarclays Capital
DatumRatingAnalyst
14.05.2019Xylem Market PerformCowen and Company, LLC
01.02.2017Xylem HoldGabelli & Co
04.05.2016Xylem NeutralWedbush Morgan Securities Inc.
11.04.2016Xylem NeutralWedbush Morgan Securities Inc.
02.11.2015Xylem Equal WeightBarclays Capital
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Xylem Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen